Eduardo Perez
Interventional Cardiology · Gainesville, FLNPI 1326400508
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (47.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 56.5% of the total. Reporting peaked in 2023 at $26,922 and has fallen 84.9% since, to $4,074 in 2025.
Across 411 payments — averaging $114.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$27K
- Abbott$11K
- Boston Scientific$2K
- Biotronik Inc.$2K
- Edwards Lifesciences$2K
- W. L. Gore & Associates, Inc.$1K
- plus $2K from 16 others
What the payments were for
- Grants$22,30047%
- Travel & lodging$11,33524%
- Food & beverage$12,97528%
- Education$4701%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 165 | $26,600 |
| Abbott | 119 | $10,711 |
| Boston Scientific | 31 | $2,384 |
| Biotronik Inc. | 15 | $2,355 |
| Edwards Lifesciences | 38 | $1,978 |
| W. L. Gore & Associates, Inc. | 7 | $1,381 |
| Pfizer | 9 | $261 |
| Amgen | 7 | $164 |
| Reflow Medical Inc | 1 | $163 |
| Cardiva Medical, Inc. | 3 | $133 |
| Mallinckrodt Enterprises LLC | 1 | $125 |
| KARL Storz Endoscopy-america | 1 | $117 |
| GSK | 1 | $115 |
| Biosense Webster, Inc. | 1 | $110 |
| Lantheus Medical Imaging, Inc. | 1 | $108 |
| Abiomed | 1 | $92 |
| Chiesi USA, Inc. | 1 | $79 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| AstraZeneca | 3 | $54 |
| Philips North America LLC | 1 | $52 |
| Novo Nordisk | 1 | $20 |
| Akcea Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$23,047
- EnSite Precision Cardiac Mapping System$2,891
- TRICLIP$1,872
- Acticor$1,573
- Rivacor$1,573
- Edora$1,573
- GENERAL - STENTS$1,300
- MitraClip$1,226
- Solia$1,049
- BioMonitor$1,049
- Edwards SAPIEN 3 Transcatheter Heart Valve$995
- HeartMate Touch$884
- GORE CARDIOFORM ASD Occluder$669
- GORE CARDIOFORM Septal Occluder$538
- Sentus$524
- Plexa$524
- CardioMEMS HF System$378
- NAVITOR$195
- Avalus$162
- Micra$154
How this compares
$47,080 in reported general payments places this provider in the 85th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Gainesville
- Arthur LeeGainesville$1.8M
- Matheen KhuddusGainesville$164K
- Christopher CaputoGainesville$67K
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.